Literature DB >> 15247167

Oesophageal cancer and gastro-oesophageal reflux: what is the relationship?

J Lagergren1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15247167      PMCID： PMC1774163          DOI： 10.1136/gut.2003.038471

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.

Authors:  D J Drewitz; R E Sampliner; H S Garewal
Journal:  Am J Gastroenterol       Date:  1997-02       Impact factor: 10.864

2.  Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.

Authors:  W Ye; W H Chow; J Lagergren; L Yin; O Nyrén
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

3.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.

Authors:  A J Cameron; B J Ott; W S Payne
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

4.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

5.  Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.

Authors:  D C Farrow; T L Vaughan; C Sweeney; M D Gammon; W H Chow; H A Risch; J L Stanford; P D Hansten; S T Mayne; J B Schoenberg; H Rotterdam; H Ahsan; A B West; R Dubrow; J F Fraumeni; W J Blot
Journal:  Cancer Causes Control       Date:  2000-03       Impact factor: 2.506

6.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

7.  Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.

Authors:  M Solaymani-Dodaran; R F A Logan; J West; T Card; C Coupland
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

8.  Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.

Authors:  Anna H Wu; Chiu-Chen Tseng; Leslie Bernstein
Journal:  Cancer       Date:  2003-09-01       Impact factor: 6.860

9.  Adenocarcinoma in Barrett's oesophagus: an overrated risk.

Authors:  A H Van der Veen; J Dees; J D Blankensteijn; M Van Blankenstein
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

10.  The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.

Authors:  W H Chow; W D Finkle; J K McLaughlin; H Frankl; H K Ziel; J F Fraumeni
Journal:  JAMA       Date:  1995-08-09       Impact factor: 56.272
  10 in total
  4 in total

1.  Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.

Authors:  Deirdre P Cronin-Fenton; Liam J Murray; David C Whiteman; Chris Cardwell; Penelope M Webb; Susan J Jordan; Douglas A Corley; Linda Sharp; Jesper Lagergren
Journal:  Eur J Cancer       Date:  2010-04-22       Impact factor: 9.162

Review 2.  Screening for oesophageal cancer.

Authors:  Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  Nat Rev Clin Oncol       Date:  2012-03-20       Impact factor: 66.675

Review 3.  Multimodal treatment of esophageal cancer.

Authors:  Florian Lordick; Arnulf H Hölscher; Karen Haustermans; Christian Wittekind
Journal:  Langenbecks Arch Surg       Date:  2012-09-13       Impact factor: 3.445

4.  Risk of gastrointestinal cancer in patients with unexplained chest/epigastric pain and normal upper endoscopy: a Danish 10-year follow-up study.

Authors:  Estrid Muff Munk; Asbjørn Mohr Drewes; Anders Gorst-Rasmussen; Peter Funch-Jensen; Hans Gregersen; Bente Nørgård
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.487
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.